ATE17736T1 - N-carboxyalkylprolin-enthaltende tripeptide. - Google Patents

N-carboxyalkylprolin-enthaltende tripeptide.

Info

Publication number
ATE17736T1
ATE17736T1 AT82305879T AT82305879T ATE17736T1 AT E17736 T1 ATE17736 T1 AT E17736T1 AT 82305879 T AT82305879 T AT 82305879T AT 82305879 T AT82305879 T AT 82305879T AT E17736 T1 ATE17736 T1 AT E17736T1
Authority
AT
Austria
Prior art keywords
prolyl
prepared
carboxyalkylproline
containing tripeptides
compounds
Prior art date
Application number
AT82305879T
Other languages
English (en)
Inventor
Francis Richard Pfeiffer
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Application granted granted Critical
Publication of ATE17736T1 publication Critical patent/ATE17736T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT82305879T 1981-11-06 1982-11-05 N-carboxyalkylprolin-enthaltende tripeptide. ATE17736T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31872181A 1981-11-06 1981-11-06
EP82305879A EP0080283B1 (de) 1981-11-06 1982-11-05 N-Carboxyalkylprolin-enthaltende Tripeptide

Publications (1)

Publication Number Publication Date
ATE17736T1 true ATE17736T1 (de) 1986-02-15

Family

ID=23239338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82305879T ATE17736T1 (de) 1981-11-06 1982-11-05 N-carboxyalkylprolin-enthaltende tripeptide.

Country Status (25)

Country Link
EP (1) EP0080283B1 (de)
JP (1) JPS5890537A (de)
KR (1) KR880002594B1 (de)
AT (1) ATE17736T1 (de)
AU (1) AU562011B2 (de)
CA (1) CA1247085A (de)
CS (1) CS235030B2 (de)
DD (1) DD206553A5 (de)
DE (1) DE3268884D1 (de)
DK (1) DK480682A (de)
ES (1) ES8401447A1 (de)
FI (1) FI75175C (de)
GR (1) GR77368B (de)
HU (1) HU187808B (de)
IE (1) IE53982B1 (de)
IL (1) IL67070A (de)
NO (1) NO160081C (de)
NZ (1) NZ202232A (de)
PH (1) PH18708A (de)
PL (1) PL136098B1 (de)
PT (1) PT75769B (de)
RO (1) RO84706B (de)
YU (1) YU245582A (de)
ZA (1) ZA827816B (de)
ZW (1) ZW23282A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0500989B1 (de) * 1991-02-27 1998-12-09 Lacer, S.A. Antihypertensive N-(alpha-substituiertes Pyridyl)-carbonyldipeptide
EP0832066B1 (de) 1995-06-06 2001-09-12 Pfizer Inc. Substituierte n-(indol-2-carbonyl)-amide und derivate als glycogen phosphorylase inhibitoren
CA2342471C (en) * 1995-06-06 2002-10-29 Judith L. Treadway Heterocyclecarbonylmethyl amine intermediates
MY114711A (en) 1995-06-06 2002-12-31 Pfizer Substituted n-(indole-2-carbonyl)-b-alanmamides and derivatives as antidiabetic agents
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
KR20040013679A (ko) * 2002-08-08 2004-02-14 현대산업개발 주식회사 실내 공기 상태 표시장치

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique

Also Published As

Publication number Publication date
RO84706B (ro) 1984-09-30
AU562011B2 (en) 1987-05-28
IL67070A (en) 1986-01-31
JPS5890537A (ja) 1983-05-30
EP0080283B1 (de) 1986-01-29
GR77368B (de) 1984-09-11
ZA827816B (en) 1983-08-31
YU245582A (en) 1985-03-20
FI823798A0 (fi) 1982-11-05
RO84706A (ro) 1984-07-17
IE53982B1 (en) 1989-05-10
ES517144A0 (es) 1983-12-16
PT75769B (en) 1985-07-26
AU9017382A (en) 1983-05-12
NZ202232A (en) 1985-08-16
CA1247085A (en) 1988-12-20
FI75175C (fi) 1988-05-09
EP0080283A1 (de) 1983-06-01
IL67070A0 (en) 1983-02-23
PL238893A1 (en) 1983-07-04
DE3268884D1 (en) 1986-03-13
NO160081B (no) 1988-11-28
ES8401447A1 (es) 1983-12-16
HU187808B (en) 1986-02-28
NO160081C (no) 1989-03-08
KR880002594B1 (ko) 1988-12-03
ZW23282A1 (en) 1983-02-23
PT75769A (en) 1982-11-01
IE822647L (en) 1983-05-06
PH18708A (en) 1985-09-05
DK480682A (da) 1983-05-07
NO823693L (no) 1983-05-09
DD206553A5 (de) 1984-02-01
FI823798L (fi) 1983-05-07
PL136098B1 (en) 1986-01-31
CS235030B2 (en) 1985-04-16
FI75175B (fi) 1988-01-29
KR840002372A (ko) 1984-06-25

Similar Documents

Publication Publication Date Title
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
ES518503A0 (es) Un metodo de preparar compuestos de fosforos.
AU5245186A (en) Oxidation resistant mutant proteins
DK70388A (da) Phosphopeptider og praeparater indeholdende disse
ATE62252T1 (de) Herstellung von peptiden und deren verwendung.
ATE17736T1 (de) N-carboxyalkylprolin-enthaltende tripeptide.
DE3684660D1 (de) Adsorption von gasen durch amin- und phosphinkomplexierte mn(ii)-verbindungen.
DE3576527D1 (de) Trennung von aminosaeureracematen.
ES8502418A1 (es) Un procedimiento para la preparacion de polipeptidos.
DK299585A (da) Fremgangsmaade til behandling af syreholdige afgangsgasser
WO1983002772A1 (en) An improved method for preparing human insulin from non-human insulin
DK466887A (da) Fremgangsmaade til koncentration af vandige aminosyreoploesninger
DE68908958D1 (de) Peptide.
DE3884798D1 (de) Tripeptide von N-3-4-Methoxyfumaryl-L-2,3-diamino-propansäure und Methode zu deren Herstellung.
SU684001A1 (ru) Способ очистки сульфата стронци
JPS64100A (en) Production of indane derivative
ES8206463A1 (es) Procedimiento de preparacion de 2-metoxi-5-aminosulfo- nil-benzamidas
KR870003601U (ko) 분뇨탱크의 배기가스 정화기
FR2589480B1 (fr) Procede biologique de preparation de n-(n-benzyloxycarbonyl l-aspartyl-1) l-phenylalaninate de methyle
IT8548675A0 (it) Borchia per l'alloggiamento a tenuta di guarnizioni per impianti idraulici
JPS54158488A (en) New disulfide compound
IT8249727A0 (it) Composto peptidico ed attivita' ipotensiva e procedimento per la sua sintesi
FI855009A7 (fi) Kalvovirtaustäyte nesteiden biologista käsittelyä varten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee